This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2007 Feb;19(1):1-8.

doi: 10.1017/s104161020600439x.

Antioxidants and Alzheimer's disease: time to stop feeding vitamin E to dementia patients?

David Ames, Craig Ritchie

PMID: 17310512
DOI: 10.1017/s104161020600439x

Free article

Editorial

Antioxidants and Alzheimer's disease: time to stop feeding vitamin E to dementia patients?

David Ames et al. Int Psychogeriatr. 2007 Feb.

Free article

. 2007 Feb;19(1):1-8.

doi: 10.1017/s104161020600439x.

Authors

David Ames, Craig Ritchie

PMID: 17310512
DOI: 10.1017/s104161020600439x

No abstract available

PubMed Disclaimer

Similar articles

Vitamin E and Alzheimer disease: the basis for additional clinical trials.
Grundman M. Grundman M. Am J Clin Nutr. 2000 Feb;71(2):630S-636S. doi: 10.1093/ajcn/71.2.630s. Am J Clin Nutr. 2000. PMID: 10681271 Review.
A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.
Sano M, Ernesto C, Thomas RG, Klauber MR, Schafer K, Grundman M, Woodbury P, Growdon J, Cotman CW, Pfeiffer E, Schneider LS, Thal LJ. Sano M, et al. N Engl J Med. 1997 Apr 24;336(17):1216-22. doi: 10.1056/NEJM199704243361704. N Engl J Med. 1997. PMID: 9110909 Clinical Trial.
Treatment of Alzheimer's disease -- searching for a breakthrough, settling for less.
Drachman DA, Leber P. Drachman DA, et al. N Engl J Med. 1997 Apr 24;336(17):1245-7. doi: 10.1056/NEJM199704243361710. N Engl J Med. 1997. PMID: 9110915 No abstract available.
[Monoamine oxidase inhibitors: prospects for the use in clinical practice].
Evtushenko SK, Lutskiĭ IS, Efimenko VN, Kazarian NE. Evtushenko SK, et al. Zh Nevrol Psikhiatr Im S S Korsakova. 2002;102(8):53-60. Zh Nevrol Psikhiatr Im S S Korsakova. 2002. PMID: 12233260 Review. Russian. No abstract available.
Therapeutic actions of L-deprenyl in dogs: a model of human brain aging.
Ruehl WW, Neilson J, Hart B, Head E, Bruyette DS, Cummings BJ. Ruehl WW, et al. Adv Pharmacol. 1998;42:316-9. doi: 10.1016/s1054-3589(08)60753-x. Adv Pharmacol. 1998. PMID: 9327904 No abstract available.

See all similar articles

Cited by

Therapeutic strategies for Alzheimer's disease.
Barten DM, Albright CF. Barten DM, et al. Mol Neurobiol. 2008 Apr-Jun;37(2-3):171-86. doi: 10.1007/s12035-008-8031-2. Epub 2008 Jun 26. Mol Neurobiol. 2008. PMID: 18581273 Review.
α-Tocopherol at nanomolar concentration protects PC12 cells from hydrogen peroxide-induced death and modulates protein kinase activities.
Zakharova IO, Sokolova TV, Bayunova LV, Vlasova YA, Rychkova MP, Avrova NF. Zakharova IO, et al. Int J Mol Sci. 2012;13(9):11543-11568. doi: 10.3390/ijms130911543. Epub 2012 Sep 14. Int J Mol Sci. 2012. PMID: 23109870 Free PMC article.
α-Tocopherol at Nanomolar Concentration Protects Cortical Neurons against Oxidative Stress.
Zakharova IO, Sokolova TV, Vlasova YA, Bayunova LV, Rychkova MP, Avrova NF. Zakharova IO, et al. Int J Mol Sci. 2017 Jan 21;18(1):216. doi: 10.3390/ijms18010216. Int J Mol Sci. 2017. PMID: 28117722 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Cambridge University Press
- Elsevier Science
Medical
- MedlinePlus Health Information